Michael E. DeBakey VA Medical Center · US
Area of research
Cardiology and Cardiovascular Medicine · Surgery
Research interest
Research interests include Lipoproteins and Cardiovascular Health, Cardiovascular Health and Risk Factors, Cardiovascular Disease and Adiposity, and Diabetes, Cardiovascular Risks, and Lipoproteins.
Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States
Atrial Fibrillation and Clonal Hematopoiesis in <i>TET2</i> and <i>ASXL1</i>
Racial and ethnic disparities in cardiovascular disease - analysis across major US national databases
Galectin‐3, Metabolic Risk, and Incident Heart Failure: The ARIC Study
Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2
Trends in cardiovascular mortality in the United States from 1968 to 2019: analysis of the CDC WONDER database
Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics: Implications for Precision Medicine—Brief Report
Intensive Blood Pressure Lowering in Patients With Malignant Left Ventricular Hypertrophy
Obesity, Galectin‐3, and Incident Heart Failure: The ARIC Study
Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey
Diabetes Duration and Subclinical Myocardial Injury: The Atherosclerosis Risk in Communities Study (ARIC)
Oral Antiplatelet Therapy After Acute Coronary Syndrome
Development and Validation of Machine Learning–Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multicohort Analysis
Duration of Diabetes and Incident Heart Failure
Upper Reference Limits for High-Sensitivity Cardiac Troponin T and N-Terminal Fragment of the Prohormone Brain Natriuretic Peptide in Patients With CKD
Recommendations for the Assessment of Carotid Arterial Plaque by Ultrasound for the Characterization of Atherosclerosis and Evaluation of Cardiovascular Risk: From the American Society of Echocardiography
Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index
Temporal Trends in E-Cigarette Use Among U.S. Adults: Behavioral Risk Factor Surveillance System, 2016 to 2018
High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study
Prediction of individualized lifetime benefit from cholesterol lowering, blood pressure lowering, antithrombotic therapy, and smoking cessation in apparently healthy people
Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline
ApoB, small-dense LDL-C, Lp(a), LpPLA <sub>2</sub> activity, and cognitive change
Trends in Blood Pressure and High-Sensitivity Cardiac Troponin-T With Cardiovascular Disease: The Cardiovascular Health Study
Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease
Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs
Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide
The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study
Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)
Obesity and Subtypes of Incident Cardiovascular Disease
Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death